Carnosine treatment in combination with ACE inhibition in diabetic rats - PubMed (original) (raw)
. 2014 Nov:194-195:36-40.
doi: 10.1016/j.regpep.2014.09.005. Epub 2014 Sep 16.
E Riedl 2, M Braunagel 2, S Höger 2, S Hauske 2, F Pfister 2, J Zschocke 3, B Lanthaler 3, U Benck 2, H-P Hammes 2, B K Krämer 2, C P Schmitt 4, B A Yard 2, H Köppel 2
Affiliations
- PMID: 25234296
- DOI: 10.1016/j.regpep.2014.09.005
Carnosine treatment in combination with ACE inhibition in diabetic rats
V Peters et al. Regul Pept. 2014 Nov.
Abstract
In humans, we reported an association of a certain allele of carnosinase gene with reduced carnosinase activity and absence of nephropathy in diabetic patients. CN1 degrades histidine dipeptides such as carnosine and anserine. Further, we and others showed that treatment with carnosine improves renal function and wound healing in diabetic mice and rats. We now investigated the effects of carnosine treatment alone and in combination with ACE inhibition, a clinically established nephroprotective drug in diabetic nephropathy. Male Sprague-Dawley rats were injected i.v. with streptozotocin (STZ) to induce diabetes. After 4 weeks, rats were unilaterally nephrectomized and randomized for 24 weeks of treatment with carnosine, lisinopril or both. Renal CN1 protein concentrations were increased under diabetic conditions which correlated with decreased anserine levels. Carnosine treatment normalized CN1 abundance and reduced glucosuria, blood concentrations of glycosylated hemoglobin (HbA1c), carboxyl-methyl lysine (CML), N-acetylglucosamine (GlcNac; all p<0.05 vs. non-treated STZ rats), reduced cataract formation (p<0.05) and urinary albumin excretion (p<0.05), preserved podocyte number (p<0.05) and normalized the increased renal tissue CN1 protein concentration. Treatment with lisinopril had no effect on HbA1C, glucosuria, cataract formation and CN1 concentration, but reduced albumin excretion rate more effectively than carnosine treatment (p<0.05). Treatment with both carnosine and lisinopril combined the effects of single treatment, albeit without additive effect on podocyte number or albuminuria. Increased CN1 amount resulted in decreased anserine levels in the kidney. Both carnosine and lisinopril exert distinct beneficial effects in a standard model of diabetic nephropathy. Both drugs administered together combine the respective effects of single treatment, albeit without exerting additive nephroprotection.
Keywords: Carnosine; Cataract; Diabetes mellitus; Diabetic nephropathy; Proteinuria.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
- Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice.
Peters V, Schmitt CP, Zschocke J, Gross ML, Brismar K, Forsberg E. Peters V, et al. Amino Acids. 2012 Jun;42(6):2411-6. doi: 10.1007/s00726-011-1046-4. Epub 2011 Aug 11. Amino Acids. 2012. PMID: 21833769 - Antioxidant effect of carnosine treatment on renal oxidative stress in streptozotocin-induced diabetic rats.
Yay A, Akkuş D, Yapıslar H, Balcıoglu E, Sonmez MF, Ozdamar S. Yay A, et al. Biotech Histochem. 2014 Nov;89(8):552-7. doi: 10.3109/10520295.2014.913811. Epub 2014 May 19. Biotech Histochem. 2014. PMID: 24834928 - Carnosine metabolism in diabetes is altered by reactive metabolites.
Peters V, Lanthaler B, Amberger A, Fleming T, Forsberg E, Hecker M, Wagner AH, Yue WW, Hoffmann GF, Nawroth P, Zschocke J, Schmitt CP. Peters V, et al. Amino Acids. 2015 Nov;47(11):2367-76. doi: 10.1007/s00726-015-2024-z. Epub 2015 Jun 17. Amino Acids. 2015. PMID: 26081982 - Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.
Peters V, Zschocke J, Schmitt CP. Peters V, et al. J Inherit Metab Dis. 2018 Jan;41(1):39-47. doi: 10.1007/s10545-017-0099-2. Epub 2017 Oct 13. J Inherit Metab Dis. 2018. PMID: 29027595 Review. - [Carnosine, carnosinase and kidney diseases].
Kiliś-Pstrusińska K. Kiliś-Pstrusińska K. Postepy Hig Med Dosw (Online). 2012 Apr 20;66:215-21. doi: 10.5604/17322693.991600. Postepy Hig Med Dosw (Online). 2012. PMID: 22706107 Review. Polish.
Cited by
- Intrinsic carnosine metabolism in the human kidney.
Peters V, Klessens CQ, Baelde HJ, Singler B, Veraar KA, Zutinic A, Drozak J, Zschocke J, Schmitt CP, de Heer E. Peters V, et al. Amino Acids. 2015 Dec;47(12):2541-50. doi: 10.1007/s00726-015-2045-7. Epub 2015 Jul 24. Amino Acids. 2015. PMID: 26206726 Free PMC article. - Carnosine Activates Cellular Stress Response in Podocytes and Reduces Glycative and Lipoperoxidative Stress.
Scuto M, Trovato Salinaro A, Modafferi S, Polimeni A, Pfeffer T, Weigand T, Calabrese V, Schmitt CP, Peters V. Scuto M, et al. Biomedicines. 2020 Jun 26;8(6):177. doi: 10.3390/biomedicines8060177. Biomedicines. 2020. PMID: 32604897 Free PMC article. - Oral anserine supplementation does not attenuate type-2 diabetes or diabetic nephropathy in BTBR ob/ob mice.
Everaert I, Van der Stede T, Stautemas J, Hanssens M, van Aanhold C, Baelde H, Vanhaecke L, Derave W. Everaert I, et al. Amino Acids. 2021 Aug;53(8):1269-1277. doi: 10.1007/s00726-021-03033-4. Epub 2021 Jul 15. Amino Acids. 2021. PMID: 34264387 - Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases.
Davies SS, Zhang LS. Davies SS, et al. Curr Pharmacol Rep. 2017 Apr;3(2):51-67. doi: 10.1007/s40495-017-0081-6. Epub 2017 Feb 14. Curr Pharmacol Rep. 2017. PMID: 28993795 Free PMC article. - Effect of Carnosine or β-Alanine Supplementation on Markers of Glycemic Control and Insulin Resistance in Humans and Animals: A Systematic Review and Meta-analysis.
Matthews JJ, Dolan E, Swinton PA, Santos L, Artioli GG, Turner MD, Elliott-Sale KJ, Sale C. Matthews JJ, et al. Adv Nutr. 2021 Dec 1;12(6):2216-2231. doi: 10.1093/advances/nmab087. Adv Nutr. 2021. PMID: 34333586 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous